TW201438600A - Nutritional compositions with heart health benefits - Google Patents
Nutritional compositions with heart health benefits Download PDFInfo
- Publication number
- TW201438600A TW201438600A TW102147329A TW102147329A TW201438600A TW 201438600 A TW201438600 A TW 201438600A TW 102147329 A TW102147329 A TW 102147329A TW 102147329 A TW102147329 A TW 102147329A TW 201438600 A TW201438600 A TW 201438600A
- Authority
- TW
- Taiwan
- Prior art keywords
- grams
- composition
- nutritional composition
- protein
- liquid nutritional
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 205
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 167
- 230000005189 cardiac health Effects 0.000 title claims abstract description 15
- 230000008901 benefit Effects 0.000 title claims description 9
- 239000007788 liquid Substances 0.000 claims abstract description 123
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 77
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 77
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 60
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 59
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 36
- 229940001941 soy protein Drugs 0.000 claims abstract description 36
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 33
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 33
- 239000000835 fiber Substances 0.000 claims description 35
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 12
- 230000036996 cardiovascular health Effects 0.000 claims description 11
- 208000019622 heart disease Diseases 0.000 claims description 11
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 10
- 239000011707 mineral Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 235000012754 curcumin Nutrition 0.000 claims description 5
- 239000004148 curcumin Substances 0.000 claims description 5
- 229940109262 curcumin Drugs 0.000 claims description 5
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 229920000294 Resistant starch Polymers 0.000 claims description 3
- 235000021254 resistant starch Nutrition 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 2
- 208000028831 congenital heart disease Diseases 0.000 claims description 2
- 235000015203 fruit juice Nutrition 0.000 claims description 2
- 241000209219 Hordeum Species 0.000 claims 3
- 238000000034 method Methods 0.000 abstract description 12
- 235000018102 proteins Nutrition 0.000 description 68
- 239000003925 fat Substances 0.000 description 29
- 235000019197 fats Nutrition 0.000 description 29
- 102000007544 Whey Proteins Human genes 0.000 description 19
- 108010046377 Whey Proteins Proteins 0.000 description 19
- 235000021119 whey protein Nutrition 0.000 description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 240000005979 Hordeum vulgare Species 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 8
- 235000010755 mineral Nutrition 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- -1 D-glucose polysaccharide Chemical class 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 235000007319 Avena orientalis Nutrition 0.000 description 5
- 244000075850 Avena orientalis Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 240000004713 Pisum sativum Species 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229940071440 soy protein isolate Drugs 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 3
- 102000011632 Caseins Human genes 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 235000010582 Pisum sativum Nutrition 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 150000001765 catechin Chemical class 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000001508 potassium citrate Substances 0.000 description 3
- 229960002635 potassium citrate Drugs 0.000 description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 3
- 235000011082 potassium citrates Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical class O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- XREGTYIADDPJMA-VIFPVBQESA-N (2s)-2-amino-6-(3-hydroxy-2-methyl-4-oxopyridin-1-yl)hexanoic acid Chemical compound CC1=C(O)C(=O)C=CN1CCCC[C@H](N)C(O)=O XREGTYIADDPJMA-VIFPVBQESA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 235000009134 Myrica cerifera Nutrition 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000061457 Solanum nigrum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FIAAVMJLAGNUKW-UHFFFAOYSA-N UNPD109131 Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C(C2C(C(O)C(O)C(CO)O2)O)=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O FIAAVMJLAGNUKW-UHFFFAOYSA-N 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- FIAAVMJLAGNUKW-CRLPPWHZSA-N Vicenin 2 Natural products O=C1c2c(O)c([C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)c(O)c([C@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)c2OC(c2ccc(O)cc2)=C1 FIAAVMJLAGNUKW-CRLPPWHZSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000010036 cardiovascular benefit Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- FIAAVMJLAGNUKW-VQVVXJKKSA-N isovitexin 8-C-beta-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O FIAAVMJLAGNUKW-VQVVXJKKSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000010150 least significant difference test Methods 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000013997 pineapple juice Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- CSNXTSWTBUEIJB-UHFFFAOYSA-N vicenin-II Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C(OC2C(C(O)C(O)C(CO)O2)O)=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O CSNXTSWTBUEIJB-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/271—Curdlan; beta-1-3 glucan; Polysaccharides produced by agrobacterium or alcaligenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
所揭示之實施例係在營養組合物之領域中,且更特定言之在提供心臟血管益處之營養組合物的領域中。 The disclosed embodiments are in the field of nutritional compositions, and more particularly in the field of nutritional compositions that provide cardiovascular benefits.
在某些應用中,液體營養組合物之澄清度可影響產品之吸引力,且影響消費者關於是否購買或食用該產品之決定。在某些應用中,液體營養組合物宜具有顯著之蛋白質含量,而在某些情況下宜具有顯著量之大豆蛋白。然而,向營養組合物中添加大量蛋白質通常與產品厚度增加或混濁外觀(或二者)相關,使所得產品略微或明顯不太宜於食用。此外,已知添加諸如β-葡聚糖之黏性纖維源同樣影響液體營養組合物之外觀。 In some applications, the clarity of the liquid nutritional composition can affect the appeal of the product and affect the consumer's decision as to whether to purchase or consume the product. In certain applications, the liquid nutritional composition preferably has a significant protein content, and in some cases it is desirable to have a significant amount of soy protein. However, the addition of large amounts of protein to the nutritional composition is often associated with increased product thickness or turbid appearance (or both), making the resulting product slightly or significantly less suitable for consumption. Furthermore, it is known that the addition of a source of viscous fibers such as β-glucan also affects the appearance of the liquid nutritional composition.
本文提供液體營養組合物(及相關方法),其適用於改善食用其之個體的心臟健康。該等液體營養組合物包括蛋白質、碳水化合物及β-葡聚糖。在某些實施例中,液體營養組合物滿足以下中之一或多者:含有至少6.25公克大豆蛋白、含有至少0.75公克β-葡聚糖、為澄清的或pH值為2至4.6。 Provided herein are liquid nutritional compositions (and related methods) that are suitable for improving the heart health of an individual eating the same. The liquid nutritional compositions include proteins, carbohydrates, and beta-glucans. In certain embodiments, the liquid nutritional composition meets one or more of the following: contains at least 6.25 grams of soy protein, contains at least 0.75 grams of beta-glucan, is clear, or has a pH of 2 to 4.6.
在第一實施例中,提供一種用於改善個體之心臟健康的澄清之液體營養組合物。該澄清之液體營養組合物包含至少一種提供每千卡 營養組合物0.004公克至0.02公克β-葡聚糖之黏性可溶性纖維源;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;且每100g營養組合物不超過1公克之脂肪。 In a first embodiment, a clear liquid nutritional composition for improving the heart health of an individual is provided. The clarified liquid nutritional composition comprises at least one per kilocalorie provided a nutritionally acceptable source of viscous soluble fiber of from 0.004 grams to 0.02 grams of beta-glucan; at least one protein source in an amount sufficient to provide from 6.25 grams to 20 grams of protein per serving; at least one carbohydrate source; and per 100 grams of nutritional composition No more than 1 gram of fat.
在第二實施例中,提供一種具有心臟健康益處之澄清之儲藏穩定的液體營養組合物。第二實施例之澄清之儲藏穩定的液體營養組合物包括至少一種量足以提供每一份9公克至15公克蛋白質之蛋白質源、至少一種碳水化合物源;每一份0.75公克至3公克β-葡聚糖纖維及每100公克營養組合物最多1公克脂肪(亦即,以液體營養組合物之總重量計不超過1重量%之脂肪)。組合物為用於改善個體心臟健康之組合物。 In a second embodiment, a clear, storage-stable liquid nutritional composition having heart health benefits is provided. The clarified storage-stable liquid nutritional composition of the second embodiment comprises at least one protein source in an amount sufficient to provide from 9 grams to 15 grams of protein per serving, at least one carbohydrate source; each 0.75 to 3 grams of beta-glucose The polysaccharide fibers and up to 1 gram of fat per 100 grams of nutritional composition (i.e., no more than 1% by weight of fat based on the total weight of the liquid nutritional composition). The composition is a composition for improving the health of an individual's heart.
在第三實施例中,提供一種用於改善個體之心臟血管健康的方法,其係藉由向有需要之個體提供包含以下之液體營養組合物來實現:每100公克營養組合物最多含有1公克總脂肪;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;維生素及礦物質;及至少一種提供每一份0.75公克與3公克之間的β-葡聚糖之黏性可溶性纖維源。食用液體營養組合物致使個體之心臟血管健康改善。 In a third embodiment, a method for improving cardiovascular health of an individual is provided by providing a liquid nutritional composition comprising the following to a subject in need thereof: up to 1 gram per 100 grams of nutritional composition Total fat; at least one protein source sufficient to provide 6.25 grams to 20 grams of protein per serving; at least one carbohydrate source; vitamins and minerals; and at least one beta-glucose between 0.75 grams and 3 grams per serving A viscous soluble fiber source of glycans. The consumption of a liquid nutritional composition results in an improvement in the cardiovascular health of the individual.
此實施例亦包括用於改善有需要之個體的心臟血管健康之液體營養組合物,其中該液體營養組合物包含:每100公克營養組合物最多1公克脂肪;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;維生素及礦物質;及至少一種提供每一份0.75公克至3公克β-葡聚糖之黏性可溶性纖維源。 This embodiment also includes a liquid nutritional composition for improving cardiovascular health of an individual in need thereof, wherein the liquid nutritional composition comprises: up to 1 gram of fat per 100 grams of nutritional composition; at least one amount sufficient to provide 6.25 per serving A protein source of grams to 20 grams of protein; at least one source of carbohydrates; vitamins and minerals; and at least one source of viscous soluble fiber providing from 0.75 grams to 3 grams of beta-glucan per serving.
此實施例亦包括液體營養組合物在製造用於改善有需要之個體的心臟血管健康之藥物中的用途,其中該液體營養組合物包含每100公克營養組合物最多1公克總脂肪;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;維生素及 礦物質;及至少一種提供每一份0.75公克與3公克之間的β-葡聚糖之黏性可溶性纖維源。 This embodiment also includes the use of a liquid nutritional composition for the manufacture of a medicament for improving cardiovascular health in an individual in need thereof, wherein the liquid nutritional composition comprises up to 1 gram of total fat per 100 grams of nutritional composition; at least one amount a protein source sufficient to provide 6.25 grams to 20 grams of protein per source; at least one carbohydrate source; vitamins and Mineral; and at least one source of viscous soluble fiber providing between 0.75 grams and 3 grams of beta-glucan per serving.
本文提供液體營養組合物(及相關方法),其適用於改善食用其之個體的心臟健康。該等液體營養組合物包括蛋白質、碳水化合物及β-葡聚糖。在某些實施例中,液體營養組合物滿足以下中之一或多者:含有至少6.25公克大豆蛋白,含有至少0.75公克β-葡聚糖,為澄清的或pH值為2至4.6。 Provided herein are liquid nutritional compositions (and related methods) that are suitable for improving the heart health of an individual eating the same. The liquid nutritional compositions include proteins, carbohydrates, and beta-glucans. In certain embodiments, the liquid nutritional composition meets one or more of the following: contains at least 6.25 grams of soy protein, contains at least 0.75 grams of beta-glucan, is clear or has a pH of 2 to 4.6.
在第一實施例中,提供一種用於改善個體之心臟健康的澄清之液體營養組合物。該澄清之液體營養組合物包含至少一種提供每千卡營養組合物0.004公克至0.02公克β-葡聚糖之黏性可溶性纖維源;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;及每100公克營養組合物最多1公克脂肪。 In a first embodiment, a clear liquid nutritional composition for improving the heart health of an individual is provided. The clarified liquid nutritional composition comprises at least one source of viscous soluble fiber providing from 0.004 grams to 0.02 grams of beta-glucan per kilocalor of nutritional composition; at least one protein in an amount sufficient to provide from 6.25 grams to 20 grams of protein per serving Source; at least one carbohydrate source; and up to 1 gram of fat per 100 grams of nutritional composition.
在第二實施例中,提供一種具有心臟健康益處之澄清之儲藏穩定的液體營養組合物。第二實施例之澄清之儲藏穩定的液體營養組合物包括至少一種量足以提供每一份9公克至15公克蛋白質之蛋白質源、至少一種碳水化合物源;每一份0.75公克至3公克β-葡聚糖纖維,及每100公克最多1公克脂肪(亦即,以液體營養組合物之總重量計不超過1重量%之脂肪)。組合物為用於改善個體心臟健康之組合物。 In a second embodiment, a clear, storage-stable liquid nutritional composition having heart health benefits is provided. The clarified storage-stable liquid nutritional composition of the second embodiment comprises at least one protein source in an amount sufficient to provide from 9 grams to 15 grams of protein per serving, at least one carbohydrate source; each 0.75 to 3 grams of beta-glucose The polysaccharide fibers, and up to 1 gram of fat per 100 grams (i.e., no more than 1% by weight of fat based on the total weight of the liquid nutritional composition). The composition is a composition for improving the health of an individual's heart.
在第三實施例中,提供一種用於改善個體之心臟血管健康的方法,其係藉由向有需要之個體提供包含以下之液體營養組合物來實現:每100公克不超過1公克之總脂肪;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;維生 素及礦物質;及至少一種提供每一份0.75公克至3公克β-葡聚糖之黏性可溶性纖維源。食用液體營養組合物致使個體之心臟血管健康改善。 In a third embodiment, a method for improving cardiovascular health of an individual is provided by providing a liquid nutritional composition comprising the following to a subject in need thereof: no more than 1 gram of total fat per 100 grams At least one protein source sufficient to provide 6.25 grams to 20 grams of protein per serving; at least one carbohydrate source; And minerals; and at least one source of viscous soluble fiber providing from 0.75 grams to 3 grams of beta-glucan per serving. The consumption of a liquid nutritional composition results in an improvement in the cardiovascular health of the individual.
此實施例亦包括一種用於改善有需要之個體的心臟血管健康之液體營養組合物,其中該液體營養組合物包含:每100公克營養組合物最多1公克脂肪;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;維生素及礦物質;及至少一種提供每一份0.75公克至3公克β-葡聚糖之黏性可溶性纖維源。 This embodiment also includes a liquid nutritional composition for improving cardiovascular health of an individual in need thereof, wherein the liquid nutritional composition comprises: up to 1 gram of fat per 100 grams of nutritional composition; at least one amount sufficient to provide each 6.25 grams to 20 grams of protein source of protein; at least one carbohydrate source; vitamins and minerals; and at least one source of viscous soluble fiber providing 0.75 grams to 3 grams of beta-glucan per serving.
此實施例亦包括液體營養組合物在製造用於改善有需要之個體的心臟血管健康之藥物中的用途,其中該液體營養組合物包含每100公克營養組合物最多1公克總脂肪;至少一種量足以提供每一份6.25公克至20公克蛋白質之蛋白質源;至少一種碳水化合物源;維生素及礦物質;及至少一種提供每一份0.75公克與3公克之間的β-葡聚糖之黏性可溶性纖維源。 This embodiment also includes the use of a liquid nutritional composition for the manufacture of a medicament for improving cardiovascular health in an individual in need thereof, wherein the liquid nutritional composition comprises up to 1 gram of total fat per 100 grams of nutritional composition; at least one amount a protein source sufficient to provide 6.25 grams to 20 grams of protein per serving; at least one carbohydrate source; vitamins and minerals; and at least one viscosity-producing solubility of between 0.75 grams and 3 grams of beta-glucan per serving Fiber source.
當論述本文所揭示之營養組合物時,該論述意欲同樣可應用於在所提出之方法中有用之營養組合物。 When discussing the nutritional compositions disclosed herein, this discussion is intended to be equally applicable to nutritional compositions useful in the proposed methods.
本文所述之營養組合物及方法適用於改善個體之心臟健康(亦即,當個體食用該等營養組合物時,該等營養組合物致使個體之心臟健康改善)。如本文所用之心臟健康與心血管疾病之發生緊密相關。亦即,在某些實施例中,心臟/心臟血管健康之改善係指心血管疾病之症狀或風險因素之降低。 The nutritional compositions and methods described herein are suitable for improving the heart health of an individual (i.e., when the individual consumes the nutritional composition, the nutritional composition results in an improvement in the heart health of the individual). Cardiac health as used herein is closely related to the development of cardiovascular disease. That is, in certain embodiments, improvement in cardiac/cardiovascular health refers to a reduction in symptoms or risk factors for cardiovascular disease.
心血管疾病係指影響心臟血管系統之任何疾病,主要為心臟疾病、大腦及腎臟之血管疾病及周邊動脈疾病。心血管疾病之病因不同,但動脈粥樣硬化及/或高血壓最常見。 Cardiovascular disease refers to any disease that affects the cardiovascular system, mainly heart disease, vascular diseases of the brain and kidneys, and peripheral arterial diseases. The causes of cardiovascular disease are different, but atherosclerosis and/or hypertension are the most common.
在第三實施例之方法中,個體可為已診斷患有心臟病狀、與心臟相關之病狀、心臟病或心臟缺陷者。或者,個體可為諸如藉由具有 一或多個以下風險因素而有發生心臟病狀或心臟病風險者:高齡(65歲或更大年齡)、男性、之前有心臟病發作或中風、高血壓、高膽固醇、吸菸者、體力不足、肥胖、高三酸甘油酯、HDL/LDL比例失衡、超重及糖尿病。改善心臟健康意謂一般心臟病狀改善(或在將另外惡化時維持原樣),此情況可藉由以下中之至少一者證明:血液膽固醇降低、血壓降低、心臟病之風險降低、重量減輕、所量測之三酸甘油酯含量降低以及其他現象。 In the method of the third embodiment, the individual may be a person who has been diagnosed with a heart condition, a condition associated with the heart, a heart disease, or a heart defect. Alternatively, the individual may be One or more of the following risk factors for heart disease or heart disease: older (65 or older), male, previous heart attack or stroke, high blood pressure, high cholesterol, smoker, physical strength Insufficient, obese, high triglycerides, HDL/LDL ratio imbalance, overweight and diabetes. Improving heart health means a general improvement in heart disease (or as it is when it worsens). This can be demonstrated by at least one of the following: lower blood cholesterol, lower blood pressure, lower risk of heart disease, weight loss, The measured triglyceride content is reduced as well as other phenomena.
所揭示實施例之營養組合物提供兩種有助於降低心臟病之風險的成分。此等成分為β-葡聚糖及大豆蛋白。大麥β-葡聚糖纖維作為心臟健康飲食之一部分可有助於降低血液膽固醇含量。包括每天3公克來自大麥β-葡聚糖之可溶性纖維的低飽和脂肪及膽固醇之飲食可降低心臟病之風險。同樣,大豆蛋白作為心臟健康飲食之一部分可有助於降低血液膽固醇含量。包括每天25公克大豆蛋白之低飽和脂肪及膽固醇之飲食可降低心臟病之風險。 The nutritional compositions of the disclosed embodiments provide two components that help reduce the risk of heart disease. These components are β-glucan and soy protein. Barley beta-glucan fiber as part of a healthy heart diet can help lower blood cholesterol levels. A diet that includes 3 grams of low-saturated fat and cholesterol from barley beta-glucan soluble fiber per day reduces the risk of heart disease. Similarly, soy protein as part of a healthy heart diet can help lower blood cholesterol levels. A diet that includes 25 grams of soy protein per day low in saturated fat and cholesterol can reduce the risk of heart disease.
總體上,如本文所闡述之術語僅用於描述實施例,且不解釋為限制本發明。 In general, the terms as set forth herein are merely used to describe the embodiments and are not to be construed as limiting the invention.
如本文所用,術語「一份」意欲解釋為意欲一次性或在在一小時或小於一小時內食用之任何量。 As used herein, the term "a copy" is intended to be interpreted as any amount intended to be consumed all at once or in one hour or less.
除非另外指定,否則如本文所用,術語「儲藏穩定」或「穩定」係指在封裝且隨後在18℃至24℃下儲存至少3個月(包括約6至12個月,且亦包括約12至18個月)之後保持商業上穩定之營養組合物。 The term "storage stable" or "stable" as used herein, unless otherwise specified, means that it is stored at 18 ° C to 24 ° C for at least 3 months (including about 6 to 12 months, and also includes about 12). A commercially stable nutritional composition is maintained after 18 months).
在本文所揭示之第一、第二及第三實施例之某些實施例中,營養組合物視需要經口投與(或食用)以提供所需營養水準。在某些此等實施例中,營養組合物以每天一至兩份之形式或以每天一或兩個或兩個以上分次劑量投與(或食用)。典型之一份量之範圍為約100mL至 500mL,包括約100mL至300mL,包括約150mL至250mL,包括約190mL至240mL,且亦包括4液盎司至10液盎司,8液盎司至10液盎司及8液盎司及10液盎司。各種卡路里含量可與每一份本文所揭示之第一、第二及第三實施例之營養組合物相關,通常為每一份25千卡至500千卡,包括50千卡至250千卡;100千卡至200千卡或150千卡至180千卡。或者,一份可解釋為意欲一次性或在一小時或小於一小時內食用之任何量。 In certain embodiments of the first, second and third embodiments disclosed herein, the nutritional composition is orally administered (or consumed) as needed to provide the desired level of nutrients. In certain such embodiments, the nutritional composition is administered (or consumed) in one to two portions per day or in one or two or more divided doses per day. A typical amount ranges from about 100 mL to 500 mL, including from about 100 mL to 300 mL, including from about 150 mL to 250 mL, including from about 190 mL to 240 mL, and also includes from 4 ounces to 10 fluid ounces, 8 fluid ounces to 10 fluid ounces, and 8 fluid ounces and 10 fluid ounces. Various calorie levels may be associated with each of the nutritional compositions of the first, second and third embodiments disclosed herein, typically from 25 kcal to 500 kcal per serving, including from 50 kcal to 250 kcal; 100 kcal to 200 kcal or 150 kcal to 180 kcal. Alternatively, a quantity may be interpreted as any amount intended to be consumed once or in one hour or less.
如先前所論述,根據第一、第二及第三實施例,液體營養組合物包括β-葡聚糖。在某些實施例中,液體營養組合物包含黏性纖維或黏性可溶性纖維。黏性纖維之特徵在於其在消化道中與水組合時形成液體或凝膠溶液之能力。已知黏性纖維在胃中與脂肪酸結合產生黏性塊狀物。黏性纖維之子集的實例包括果膠,諸如在蘋果中發現之果膠;β-葡聚糖;瓜爾膠;及黏液,諸如洋車前子殼粉。β-葡聚糖為天然可溶性纖維源。已證明可溶性纖維(或黏性纖維)會降低LDL膽固醇,且已鑑別其為維持健康之血糖含量提供益處。β-葡聚糖分子由D-葡萄糖多醣之連接鏈組成。儘管相似,但β-葡聚糖更不同於如澱粉之分子。一些β-葡聚糖呈單股鏈形式存在,而其他具有複雜之螺旋排列。特定排列通常由β-葡聚糖源所致,其中一些稱為β(1,3)(1,4)之排列展示令人感興趣之生物活性。一些已知β-葡聚糖源為穀物,諸如大麥、燕麥、黑小麥、小麥、水稻、玉米、莧菜及鵝腳藜以及其他穀物。一般而言,自穀粒中提取之β-葡聚糖為可溶與不可溶的,而來自麵包酵母之β-葡聚糖主要為不可溶的。 As previously discussed, according to the first, second and third embodiments, the liquid nutritional composition comprises beta-glucan. In certain embodiments, the liquid nutritional composition comprises viscous fibers or viscous soluble fibers. Viscous fibers are characterized by their ability to form a liquid or gel solution when combined with water in the digestive tract. Viscous fibers are known to bind to fatty acids in the stomach to produce a viscous mass. Examples of a subset of viscous fibers include pectin, such as pectin found in apples; beta-glucan; guar gum; and mucus, such as psyllium husk powder. Beta-glucan is a source of natural soluble fiber. Soluble fibers (or viscous fibers) have been shown to lower LDL cholesterol and have been identified as providing benefits in maintaining healthy blood glucose levels. The β-glucan molecule consists of a linking chain of D-glucose polysaccharide. Although similar, β-glucan is more different from molecules such as starch. Some beta-glucans are present in a single stranded form, while others have a complex helical arrangement. The particular arrangement is usually caused by a source of beta-glucan, some of which are known as the arrangement of beta (1,3) (1,4) exhibiting interesting biological activity. Some known sources of beta-glucan are cereals such as barley, oats, triticale, wheat, rice, corn, leeks and goose feet and other cereals. In general, β-glucan extracted from grain is soluble and insoluble, while β-glucan from baker's yeast is mainly insoluble.
當在本文所揭示之液體營養組合物中利用β-葡聚糖時,β-葡聚糖可藉由單個來源或一種以上來源提供。在某些實施例中,β-葡聚糖可以其天然形式提供。相反,在第一、第二及第三實施例之某些實施例中,所利用之β-葡聚糖呈含有β-葡聚糖之穀物的改質形式。已報導分 離之燕麥及大麥β-葡聚糖之重量平均分子量為約1,000,000Da,但尚未報導穀物β-葡聚糖之分子量。改質β-葡聚糖之重量平均分子量可為50kDa至1000kDa,包括120kDa至170kDa。改質β-葡聚糖的重量平均分子量範圍可藉由熟習此項技術者所熟知之任何製程達成,包括使用酶或酶之組合以執行穀物之非特異性消化。改質β-葡聚糖可具有改變之生理化學特性,包括降低之黏度、非膠凝特徵及於水中之高溶解度。所利用之β-葡聚糖可高度溶於水且形成具有低黏度之溶液。舉例而言,含有1%改質β-葡聚糖之溶液在25℃下之黏度將為1cps至1000cps。 When beta-glucan is utilized in the liquid nutritional compositions disclosed herein, the beta-glucan can be provided by a single source or from more than one source. In certain embodiments, the beta glucan can be provided in its native form. In contrast, in certain embodiments of the first, second and third embodiments, the beta glucan utilized is in a modified form of a beta-glucan containing cereal. Reported points The weight average molecular weight of the oat and barley beta-glucan from the oats is about 1,000,000 Da, but the molecular weight of the cereal beta glucan has not been reported. The modified β-glucan may have a weight average molecular weight of from 50 kDa to 1000 kDa, including from 120 kDa to 170 kDa. The weight average molecular weight range of the modified beta-glucan can be achieved by any process well known to those skilled in the art, including the use of a combination of enzymes or enzymes to perform non-specific digestion of the grain. Modified beta-glucan can have altered physiochemical properties including reduced viscosity, non-gelling characteristics, and high solubility in water. The β-glucan utilized can be highly soluble in water and form a solution having a low viscosity. For example, a solution containing 1% modified beta-glucan will have a viscosity of 1 cps to 1000 cps at 25 °C.
如先前所論述,根據第一實施例,β-葡聚糖之存在量為每千卡液體營養組合物0.004公克至0.02公克。在第一實施例之其他實施例中,β-葡聚糖之存在量為每千卡液體營養組合物0.005公克至0.010公克。所利用之β-葡聚糖的特定量可根據液體營養組合物中之總卡路里而改變。此外,在第一實施例之某些實施例中,β-葡聚糖之存在量為每份0.75公克至3公克。如先前所論述,合適之β-葡聚糖源包括燕麥及大麥。一種大麥β-葡聚糖源係由Cargill Corporation(15407 McGinty Road West MS 110 Wayzata,MN 55391)以商品名BarlivTM銷售。在第一實施例之某些實施例中,β-葡聚糖來源於大麥。 As previously discussed, according to the first embodiment, the beta glucan is present in an amount from 0.004 grams to 0.02 grams per kilocalorie of the liquid nutritional composition. In other embodiments of the first embodiment, the beta glucan is present in an amount from 0.005 grams to 0.010 grams per kilocalorie of the liquid nutritional composition. The specific amount of beta-glucan utilized can vary depending on the total calories in the liquid nutritional composition. Furthermore, in certain embodiments of the first embodiment, the beta glucan is present in an amount from 0.75 grams to 3 grams per serving. As discussed previously, suitable sources of beta-glucan include oats and barley. One kind of barley β- glucan source lines (15407 McGinty Road West MS 110 Wayzata , MN 55391) by the Cargill Corporation sold under the trade name Barliv TM. In certain embodiments of the first embodiment, the beta glucan is derived from barley.
如先前所論述,根據本文所揭示之第二及第三實施例,β-葡聚糖之存在量為每份0.75公克至3公克。在本文所揭示之某些實施例中,β-葡聚糖之存在量為每份0.75公克至1.5公克。在本文所揭示之第二及第三實施例之某些實施例中,β-葡聚糖來源於大麥。在本文所揭示之第二及第三實施例之某些實施例中,β-葡聚糖係由一種以上來源提供,諸如大麥及燕麥,每份包含大麥0.75公克至3公克。 As previously discussed, according to the second and third embodiments disclosed herein, the beta glucan is present in an amount from 0.75 grams to 3 grams per serving. In certain embodiments disclosed herein, the beta glucan is present in an amount from 0.75 grams to 1.5 grams per serving. In certain embodiments of the second and third embodiments disclosed herein, the beta glucan is derived from barley. In certain embodiments of the second and third embodiments disclosed herein, the beta-glucan is provided from more than one source, such as barley and oats, and each portion comprises from 0.75 grams to 3 grams of barley.
如先前所論述,根據本文所揭示之第一及第二實施例,液體營養組合物為澄清的。此外,在本文所揭示之第三實施例之某些實施例 中,液體營養組合物為澄清的。除非另外指定,否則本文所用之術語澄清係指非乳化或類似具有明顯澄清或半透明外觀之其他液體。在本文所揭示之第一、第二及第三實施例之某些實施例中,澄清之液體營養組合物呈澄清液體形式。在此文中,用Nephla讀取器在90度光散射及860nm以福爾馬肼濁度單位(formazin nephelometric unit;FNU)測量清澈度或澄清度。本文所用之澄清液體營養組合物係指FNU低於50(亦即3至50),低於40(亦即3至40)及在其他實施例中低於30(亦即3至30)之澄清液體營養組合物。 As previously discussed, the liquid nutritional composition is clear according to the first and second embodiments disclosed herein. Moreover, certain embodiments of the third embodiment disclosed herein The liquid nutritional composition is clear. The term clarification as used herein, unless otherwise specified, refers to non-emulsified or similar other liquids having a distinctly clear or translucent appearance. In certain embodiments of the first, second and third embodiments disclosed herein, the clarified liquid nutritional composition is in the form of a clear liquid. In this context, the clarity or clarity was measured with a Nephla reader at 90 degrees light scattering and at 860 nm in a formazin nephelometric unit (FNU). As used herein, a clarified liquid nutritional composition refers to a clarification of FNU less than 50 (i.e., 3 to 50), less than 40 (i.e., 3 to 40), and in other embodiments less than 30 (i.e., 3 to 30). Liquid nutritional composition.
在第一、第二及第三實施例之某些實施例中,液體營養組合物含有一或多種纖維源(除β-葡聚糖之外)。在某些此等實施例中,營養組合物每一份包含1公克至6公克總纖維,且所包括之纖維包含至少0.75公克β-葡聚糖,其餘纖維由一或多種其他纖維源製成。適用於液體營養組合物之例示性纖維源(除β-葡聚糖之外)為由Roquette公司(62136 Lestrem France)以商品名Nutriose®銷售之抗性澱粉。 In certain embodiments of the first, second and third embodiments, the liquid nutritional composition contains one or more sources of fiber (other than beta-glucan). In certain such embodiments, the nutritional composition comprises from 1 g to 6 g of total fiber per part, and the fibers included comprise at least 0.75 g of beta glucan, the remaining fibers being made from one or more other fiber sources . An exemplary fiber source (other than beta-glucan) suitable for use in a liquid nutritional composition is a resistant starch sold under the trade name Nutriose® by Roquette Corporation (62136 Lestrem France).
如先前所論述,根據第一及第三實施例,營養組合物包括至少一種量足以提供總量在每一份6.25公克與20公克之間的蛋白質之蛋白質源,且根據第二實施例,營養組合物包括至少一種量足以提供總量為每一份9公克至15公克之蛋白質之蛋白質源。視第一、第二及第三實施例之液體營養組合物中蛋白質之總量而定,蛋白質可藉由單一蛋白質源或蛋白質源之組合提供。在本文所揭示之第一、第二及第三實施例之液體營養組合物之某些實施例中,大豆蛋白佔總蛋白質之30重量%至100重量%,且乳清蛋白分離物佔總蛋白質之0重量%至70重量%。 As previously discussed, according to the first and third embodiments, the nutritional composition comprises at least one protein source in an amount sufficient to provide a total amount of protein between 6.25 and 20 grams per serving, and according to the second embodiment, nutrition The composition includes at least one protein source in an amount sufficient to provide a total amount of from 9 grams to 15 grams of protein per serving. Depending on the total amount of protein in the liquid nutritional compositions of the first, second and third embodiments, the protein may be provided by a single protein source or a combination of protein sources. In certain embodiments of the liquid nutritional compositions of the first, second and third embodiments disclosed herein, the soy protein comprises from 30% to 100% by weight of the total protein, and the whey protein isolate comprises the total protein 0% by weight to 70% by weight.
當大豆蛋白用於本文所揭示之第一及第三實施例之液體營養組合物中及本文所揭示之第二實施例之液體營養組合物中(其含有至少6.25公克大豆蛋白)時,大豆蛋白可藉由一或多種大豆蛋白源提供。 大豆蛋白之常見形式包括大豆蛋白濃縮物、大豆蛋白分離物(包括酸化之大豆蛋白分離物)及大豆蛋白水解產物。如先前所論述,在總蛋白質之某些實施例(亦即,0重量%至100重量%)中,在液體營養組合物中所利用之大豆蛋白的量高達總蛋白質之100重量%,在某些其他實施例中,大豆蛋白之量為總蛋白質之30重量%至70重量%。在第一、第二及第三實施例之某些實施例中,大豆蛋白為大豆蛋白分離物。在第一、第二及第三實施例之某些實施例中,其中總蛋白質之含量為每一份6.25公克,大豆蛋白較佳佔總蛋白質之100%。在第一、第二及第三實施例之某些實施例中,大豆蛋白為經處理以用於pH值小於4.6之液體營養組合物之大豆蛋白分離物。為達成此處理水準,可藉由超濾來分離大豆蛋白分離物。商業大豆蛋白源在營養技術中已熟知,其非限制性實例包括藉由ADM Specialty Products(4666 East Faries Parkway Decatur,IL 62526)以商品名Clarisoy銷售之大豆蛋白分離物。 Soy protein when soy protein is used in the liquid nutritional compositions of the first and third embodiments disclosed herein and in the liquid nutritional composition of the second embodiment disclosed herein, which contains at least 6.25 grams of soy protein It can be provided by one or more soy protein sources. Common forms of soy protein include soy protein concentrates, soy protein isolates (including acidified soy protein isolates), and soy protein hydrolysates. As previously discussed, in certain embodiments of total protein (ie, 0% to 100% by weight), the amount of soy protein utilized in the liquid nutritional composition is up to 100% by weight of the total protein, at some In other embodiments, the amount of soy protein is from 30% to 70% by weight of the total protein. In certain embodiments of the first, second and third embodiments, the soy protein is a soy protein isolate. In certain embodiments of the first, second and third embodiments, wherein the total protein content is 6.25 grams per serving, the soy protein preferably comprises 100% of the total protein. In certain embodiments of the first, second and third embodiments, the soy protein is a soy protein isolate treated for use in a liquid nutritional composition having a pH of less than 4.6. To achieve this level of treatment, the soy protein isolate can be isolated by ultrafiltration. Commercial soy protein sources are well known in nutritional technology, non-limiting examples of which include soy protein isolates sold under the tradename Clarisoy by ADM Specialty Products (4666 East Faries Parkway Decatur, IL 62526).
當乳清蛋白用於本文所揭示之第一、第二及第三實施例之液體營養組合物中時,乳清可藉由一種或一種以上來源提供。乳清蛋白之常見形式包括乳清蛋白濃縮物、乳清蛋白水解產物及乳清蛋白分離物。乳清蛋白較佳以乳清蛋白分離物形式存在。存在含有不同濃度蛋白質之各種商業乳清蛋白源,諸如約75重量%蛋白質(w/w,以蛋白質源之總重量計)。如先前所論述,在某些實施例中,用於液體營養組合物中之乳清蛋白之量可高達總蛋白質之70重量%(亦即,0重量%至70重量%)。在第一、第二及第三實施例之實施例中,其中液體營養組合物之總蛋白質含量較高(諸如更接近20公克或為20公克),乳清蛋白之量可多至總蛋白質之70%,例如每一份1公克至13公克。在第一、第二及第三實施例之實施例中,其中液體營養組合物之總蛋白質含量較低(例如約6.25公克),乳清較佳佔總蛋白質之1%以下。 When whey protein is used in the liquid nutritional compositions of the first, second and third embodiments disclosed herein, the whey may be provided by one or more sources. Common forms of whey protein include whey protein concentrate, whey protein hydrolysate, and whey protein isolate. The whey protein is preferably present in the form of a whey protein isolate. There are various commercial whey protein sources containing different concentrations of protein, such as about 75% by weight protein (w/w, based on the total weight of the protein source). As previously discussed, in certain embodiments, the amount of whey protein used in the liquid nutritional composition can be up to 70% by weight of the total protein (ie, from 0% to 70% by weight). In the examples of the first, second and third embodiments, wherein the total protein content of the liquid nutritional composition is higher (such as closer to 20 grams or 20 grams), the amount of whey protein can be as much as total protein. 70%, for example, 1 to 13 grams per serving. In the examples of the first, second and third embodiments, wherein the total protein content of the liquid nutritional composition is low (e.g., about 6.25 grams), the whey preferably comprises less than 1% of the total protein.
除上文所論述之蛋白質源之外,在某些實施例中,本文所揭示之第一、第二及第三實施例之液體營養組合物亦可含有來自一或多種其他來源之蛋白質,其量與上文所論述之大豆蛋白量及乳清蛋白量之導引一致。一般根據第一、第二及第三實施例,其他蛋白質源(當存在時)將佔(總計)總蛋白質之不超過40重量%(亦即,0重量%至40重量%)、不超過30重量%、不超過20重量%或不超過10重量%。在液體營養組合物澄清之彼等實施例中,合適之其他蛋白質源(亦即,除大豆蛋白之外)包括諸如酪蛋白水解產物之某些基於酪蛋白之蛋白質;諸如豌豆水解產物之某些基於豌豆之蛋白質;及其類似物。至少一種蛋白質源可包括上文所列之各種蛋白質源的任何個體或其組合。在本文所揭示之第三實施例的彼等實施例中,其中液體營養組合物不澄清,一或多種其他蛋白質源(量不超過總蛋白質之40重量%(亦即,0重量%至40重量%),或者不超過30重量%,不超過20重量%或甚至不超過10重量%之,考慮上文所論述之大豆蛋白及乳清蛋白之指定量)包括乳蛋白濃縮物、大豆蛋白濃縮物、來自牛奶之酪蛋白、動物產物(例如肉類、魚、卵蛋白、膠原蛋白)、穀物(例如水稻,玉米)、蔬菜(例如大豆、豌豆、馬鈴薯、鵝腳藜)、膠原蛋白或其組合。其他蛋白質源亦可包括已知用於營養組合物之游離胺基酸,其非限制性實例包括色胺酸、麩醯胺酸、酪胺酸、L-甲硫胺酸、半胱胺酸、牛磺酸、L-精胺酸、肉鹼及其組合。 In addition to the protein sources discussed above, in certain embodiments, the liquid nutritional compositions of the first, second, and third embodiments disclosed herein may also contain proteins from one or more other sources, The amount is consistent with the guidance of the amount of soy protein and the amount of whey protein discussed above. Generally according to the first, second and third embodiments, other protein sources (when present) will account for no more than 40% by weight (i.e., 0% to 40% by weight) of the total protein (not more than 30%) % by weight, not more than 20% by weight or not more than 10% by weight. In other embodiments in which the liquid nutritional composition is clarified, suitable other protein sources (ie, in addition to soy protein) include certain casein-based proteins such as casein hydrolysates; certain such as pea hydrolysates Pea-based proteins; and analogs thereof. The at least one protein source can include any individual or combination of various protein sources listed above. In such embodiments of the third embodiment disclosed herein, wherein the liquid nutritional composition is not clear, one or more other protein sources (the amount does not exceed 40% by weight of the total protein (ie, 0% to 40% by weight) %), or no more than 30% by weight, no more than 20% by weight or even no more than 10% by weight, considering the specified amounts of soy protein and whey protein discussed above) including milk protein concentrate, soy protein concentrate Casein from milk, animal products (eg meat, fish, egg white, collagen), cereals (eg rice, corn), vegetables (eg soybean, pea, potato, goose's ankle), collagen or a combination thereof. Other protein sources may also include free amino acids known for use in nutritional compositions, non-limiting examples of which include tryptophan, glutamic acid, tyrosine, L-methionine, cysteine, Taurine, L-arginine, carnitine, and combinations thereof.
如先前所論述,本文所揭示之第一、第二及第三實施例之液體營養組合物含有至少一種碳水化合物源,在某些實施例中含有一種以上來源。液體營養組合物中碳水化合物之特定含量可視預期使用者之營養需求而變化。本文所揭示之第一、第二及第三實施例之液體營養組合物中碳水化合物之總含量通常將屬於5重量%至40重量%(百分比為以液體營養組合物之總重量計的重量百分比)、7重量%至30重量% 或10重量%至20重量%之範圍。本文所揭示之第一、第二及第三實施例之液體營養組合物中碳水化合物之含量亦可以液體營養組合物中之總卡路里的百分比表徵且可廣泛變化。在本文所揭示之第一、第二及第三實施例之某些實施例中,至少一種碳水化合物源佔液體營養組合物之總卡路里的10%至85%,且在其他實施例中佔總卡路里之20%至60%。在某些實施例中,液體營養組合物包括至少一種量足以提供每公升液體營養組合物總共100公克至200公克碳水化合物之碳水化合物源。 As previously discussed, the liquid nutritional compositions of the first, second, and third embodiments disclosed herein contain at least one carbohydrate source, and in some embodiments, more than one source. The specific amount of carbohydrate in the liquid nutritional composition may vary depending on the nutritional needs of the intended user. The total carbohydrate content of the liquid nutritional compositions of the first, second and third embodiments disclosed herein will generally be from 5% to 40% by weight (percentage by weight based on the total weight of the liquid nutritional composition) ), 7 wt% to 30 wt% Or in the range of 10% by weight to 20% by weight. The carbohydrate content of the liquid nutritional compositions of the first, second and third embodiments disclosed herein can also be characterized by the percentage of total calories in the liquid nutritional composition and can vary widely. In certain embodiments of the first, second and third embodiments disclosed herein, the at least one carbohydrate source comprises from 10% to 85% of the total calories of the liquid nutritional composition, and in other embodiments 20% to 60% of calories. In certain embodiments, the liquid nutritional composition includes at least one carbohydrate source in an amount sufficient to provide a total of from 100 grams to 200 grams of carbohydrate per liter of liquid nutritional composition.
存在各種商業碳水化合物源,且可用於本文所揭示之液體營養組合物。適用於本文所揭示之液體營養組合物之碳水化合物或其來源的非限制性實例包括:麥芽糊精、水解或改質之澱粉或玉米澱粉、葡萄糖聚合物、玉米糖漿、玉米糖漿固體、來源於水稻之碳水化合物、葡萄糖、果糖、乳糖、高果糖玉米糖漿、蜂蜜、糖醇類(例如麥芽糖醇、赤藻糖醇、山梨醇)、緩慢消化碳水化合物(例如舒可慢(sucromalt)、異麥芽酮糖α環糊精、γ環糊精、普魯蘭(pullulan)、木薯澱粉糊精、半乳寡醣、異麥芽寡醣、綠豆碳水化合物、綠豌豆碳水化合物及桃子碳水化合物以及其他碳水化合物)及其組合。 There are a variety of commercial carbohydrate sources and are useful in the liquid nutritional compositions disclosed herein. Non-limiting examples of carbohydrates or sources thereof suitable for use in the liquid nutritional compositions disclosed herein include: maltodextrin, hydrolyzed or modified starch or corn starch, glucose polymer, corn syrup, corn syrup solids, sources In rice, carbohydrate, glucose, fructose, lactose, high fructose corn syrup, honey, sugar alcohols (such as maltitol, erythritol, sorbitol), slowly digesting carbohydrates (such as sucromalt, different) Maltosine alpha cyclodextrin, gamma cyclodextrin, pullulan, tapioca dextrin, galactooligosaccharides, isomalto-oligosaccharides, mung bean carbohydrates, green pea carbohydrates, and peach carbohydrates Other carbohydrates) and combinations thereof.
在本文所揭示之第一、第二及第三實施例之某些實施例中,限制用於至少一種碳水化合物組分之糖的量。在某些此等實施例中,糖之總量低於每一份18公克或每8盎司份低於18公克,且甚至低至每一份13公克或每8盎司份低於13公克。 In certain embodiments of the first, second and third embodiments disclosed herein, the amount of sugar for at least one carbohydrate component is limited. In some such embodiments, the total amount of sugar is less than 18 grams per serving or less than 18 grams per 8 ounces, and even as low as 13 grams per serving or less than 13 grams per 8 ounces.
如先前所論述,本文所揭示之第一、第二及第三實施例之營養組合物內所含之脂肪的量相對少(亦即,每100公克第一及第三實施例之營養組合物不超過1公克脂肪,且以第二實施例之營養組合物之總重量計,不超過1重量%之脂肪)。在本文所揭示之第一、第二及第三實施例之其他實施例中,以液體營養組合物之總重量計,液體組合物 內所含之脂肪的總量為0.5重量%或0.5重量%以下,或0.1重量%或0.1重量%以下。一般而言,當將液體營養組合物調配至澄清時,限制可添加至組合物中之脂肪的量。所存在之脂肪的量亦可以液體營養組合物中之總卡路里的百分比表徵,且可視液體營養組合物中之卡路里總數而變化,但(考慮上文所論述之脂肪參數)一般低於液體營養組合物之總卡路里之10%或甚至低於總卡路里之5%。 As previously discussed, the amount of fat contained in the nutritional compositions of the first, second and third embodiments disclosed herein is relatively small (i.e., every 100 grams of the nutritional compositions of the first and third embodiments) Not more than 1 gram of fat, and not more than 1% by weight of the total weight of the nutritional composition of the second embodiment). In other embodiments of the first, second and third embodiments disclosed herein, the liquid composition is based on the total weight of the liquid nutritional composition The total amount of fat contained therein is 0.5% by weight or less, or 0.1% by weight or less, or 0.1% by weight or less. In general, when the liquid nutritional composition is formulated to clarify, the amount of fat that can be added to the composition is limited. The amount of fat present may also be characterized by the percentage of total calories in the liquid nutritional composition, and may vary depending on the total number of calories in the liquid nutritional composition, but (considering the fat parameters discussed above) is generally lower than the liquid nutritional combination. 10% of the total calories of the substance or even 5% of the total calories.
在本文所揭示之第一、第二及第三實施例之彼等實施例中,其中存在一定量之脂肪,脂肪之存在可為固有地存在於另一成分中(例如蛋白質源)之結果,或其存在可為作為更多各別脂肪源中之一者添加之結果。存在各種商業脂肪源,且可用於本文所揭示之液體營養組合物。適用於本文所揭示之液體營養組合物的合適脂肪或其來源的非限制性實例包括椰子油、分餾之椰子油、大豆油、玉米油、橄欖油、紅花油、高油酸紅花油、MCT油(中鏈三酸甘油酯)、葵花籽油、高油酸葵花籽油、棕櫚油及棕櫚仁油、棕櫚液油、菜籽油、水產動物油、棉籽油及其組合。 In the embodiments of the first, second and third embodiments disclosed herein, wherein a certain amount of fat is present, the presence of fat may be the result of being inherently present in another component (eg, a protein source), Or its presence may be the result of being added as one of more individual fat sources. There are a variety of commercial fat sources and can be used in the liquid nutritional compositions disclosed herein. Non-limiting examples of suitable fats or sources thereof suitable for use in the liquid nutritional compositions disclosed herein include coconut oil, fractionated coconut oil, soybean oil, corn oil, olive oil, safflower oil, high oleic safflower oil, MCT oil. (medium chain triglyceride), sunflower oil, high oleic sunflower oil, palm oil and palm kernel oil, palm oil, rapeseed oil, aquatic animal oil, cottonseed oil and combinations thereof.
在第一、第二及第三實施例之某些實施例中,液體營養組合物包括L-肉鹼。L-肉鹼為涉及在體內使脂肪轉化成能量之生物學活性化合物。在某些此等實施例中,L-肉鹼之含量為每一份50mg至250mg。在本文所揭示之第一、第二及第三實施例之某些實施例中,L-肉鹼之含量為每一份75mg至150mg之間,或每一份100mg至125mg之間。在本文所揭示之第一、第二及第三實施例之其他實施例中,L-肉鹼之含量為每一份至少100mg。 In certain embodiments of the first, second and third embodiments, the liquid nutritional composition comprises L-carnitine. L-carnitine is a biologically active compound that involves the conversion of fat into energy in the body. In certain such embodiments, the L-carnitine is present in an amount from 50 mg to 250 mg per serving. In certain embodiments of the first, second and third embodiments disclosed herein, the L-carnitine is present in an amount between 75 mg and 150 mg per serving, or between 100 mg and 125 mg per serving. In other embodiments of the first, second and third embodiments disclosed herein, the L-carnitine is present in an amount of at least 100 mg per serving.
在第一、第二及第三實施例之某些實施例中,營養組合物包括薑黃素。薑黃素之攝取已經與血液三酸甘油酯之降低有關,然而,在人類個體中,當薑黃素呈天然存在之形式時,其一般展現不佳之生物可用性。當薑黃素存在於本文所揭示之第一、第二及第三實施例之營 養組合物中時,其含量為每一份5mg至150mg。 In certain embodiments of the first, second and third embodiments, the nutritional composition comprises curcumin. The intake of curcumin has been associated with a decrease in blood triglycerides, however, in human subjects, when curcumin is in a naturally occurring form, it generally exhibits poor bioavailability. When curcumin is present in the camps of the first, second and third embodiments disclosed herein When the composition is raised, it is contained in an amount of from 5 mg to 150 mg per part.
另外,在本文所揭示之第一、第二及第三實施例之某些實施例中,本文所揭示之營養組合物含有多酚,包括來自綠茶之多酚。在某些該等實施例中,多酚之量為每一份營養組合物100mg至500mg。已知綠茶及來自其萃取物含有EGCg。EGCg為為許多治療及營養益處所需之多酚,特定言之兒茶素。EGCg為存在於綠茶中之最豐富的多酚。與本文所揭示之儲藏穩定之澄清液體營養組合物一起使用的綠茶萃取物亦可含有其他多酚,包括其他兒茶素類,諸如兒茶素(亦即,(+)-兒茶素,亦稱為「C」)、表兒茶素(「EC」)、沒食子兒茶素(「GC」)、表沒食子兒茶素(「EGC」)及表兒茶素沒食子酸酯(「ECg」);黃酮類,諸如芹菜素、異牡荊素(isoviloxin)、皂草苷(sapotarin)及巢菜素-2(vicenin-2);黃酮醇類,諸如山奈酚、槲皮素、楊梅皮黃素;濃縮黃烷類及丹寧酸醣苷類。此外,所揭示之實施例亦可含有來自諸如果實(例如李/梅或李/梅萃取物)或可可粉之其他來源的多酚。 Additionally, in certain embodiments of the first, second, and third embodiments disclosed herein, the nutritional compositions disclosed herein comprise polyphenols, including polyphenols from green tea. In certain such embodiments, the amount of polyphenol is from 100 mg to 500 mg per serving of the nutritional composition. Green tea and its extracts are known to contain EGCg. EGCg is a polyphenol required for many therapeutic and nutritional benefits, specifically catechins. EGCg is the most abundant polyphenol present in green tea. The green tea extract used with the storage-stable clear liquid nutritional composition disclosed herein may also contain other polyphenols, including other catechins, such as catechins (ie, (+)-catechin, also Called "C"), epicatechin ("EC"), gallocatechin ("GC"), epigallocatechin ("EGC"), and epicatechin gallate Esters ("ECg"); flavonoids, such as apigenin, isoviloxin, sapotarin and vicenin-2; flavonols such as kaempferol, suede Vegetarian, bayberry flavin; concentrated flavans and tannin glycosides. In addition, the disclosed embodiments may also contain polyphenols from other sources such as fruits (e.g., plum/lime or plum/ume extract) or cocoa powder.
在第一、第二及第三實施例之某些實施例中,液體營養組合物之pH在2與4.6之間。一般而言,需要使pH大於4.6之液體營養組合物在銷售給公眾之前經更顯著之熱處理。熱處理之降低量使酸性調配物對於某些應用具有吸引力。 In certain embodiments of the first, second and third embodiments, the pH of the liquid nutritional composition is between 2 and 4.6. In general, it is desirable to have a more significant heat treatment of the liquid nutritional composition having a pH greater than 4.6 prior to sale to the public. The reduced amount of heat treatment makes the acidic formulation attractive for certain applications.
在本文所揭示之第一、第二及第三實施例之某些實施例中,液體營養組合物包括果汁。在某些該等實施例中,果汁用作一部分淡水之替代物、用作所有或一部分甜味劑之替代物、或以上二者,可另外存在於液體營養組合物中。視類型及量而定,果汁將提供一定量之水及甜味劑。果汁可來自一或多種來源。適用於本文所揭示之液體營養組合物之果汁的水果來源之一些非限制性實例包括:葡萄、蘋果、蔓越莓、橙、桃、藍莓、石榴、鳳梨汁、漿果汁摻合物,及其組合,不 論來自習知或有機來源且不論濃縮或非濃縮。適用於所揭示實施例之果汁摻合物應與先前關於營養組合物澄清度之論述一致。 In certain embodiments of the first, second and third embodiments disclosed herein, the liquid nutritional composition comprises fruit juice. In certain such embodiments, the juice is used as a substitute for a portion of fresh water, as a substitute for all or a portion of the sweetener, or both, and may additionally be present in the liquid nutritional composition. Depending on the type and amount, the juice will provide a certain amount of water and sweetener. Juice can come from one or more sources. Some non-limiting examples of fruit sources suitable for use in the juices of the liquid nutritional compositions disclosed herein include: grapes, apples, cranberries, oranges, peaches, blueberries, pomegranates, pineapple juices, juice blends, and Combination, no From conventional or organic sources, whether concentrated or non-concentrated. Juice blends suitable for use in the disclosed embodiments should be consistent with previous statements regarding the clarity of the nutritional composition.
在本文所揭示之第一、第二及第三實施例之某些實施例中,液體營養組合物含有其他成分,其非限制性實例包括防腐劑、抗氧化劑、乳化劑、緩衝劑、醫藥活性劑、其他營養物、著色劑、香料、增稠劑及穩定劑。 In certain embodiments of the first, second, and third embodiments disclosed herein, the liquid nutritional composition contains other ingredients, non-limiting examples of which include preservatives, antioxidants, emulsifiers, buffers, pharmaceutically active agents Agents, other nutrients, colorants, fragrances, thickeners and stabilizers.
在本文所揭示之第一、第二及第三實施例之某些實施例中,液體營養組合物含有維生素或相關營養物,其非限制性實例包括維生素A、維生素E、維生素K、硫胺素、核黃素、吡哆醇、維生素B12、類胡蘿蔔素、菸酸、葉酸、泛酸、生物素、維生素C、膽鹼、肌醇、其鹽及衍生物,及其組合。 In certain embodiments of the first, second and third embodiments disclosed herein, the liquid nutritional composition contains vitamins or related nutrients, non-limiting examples of which include vitamin A, vitamin E, vitamin K, thiamine , riboflavin, pyridoxine, vitamin B12, carotenoids, niacin, folic acid, pantothenic acid, biotin, vitamin C, choline, inositol, salts and derivatives thereof, and combinations thereof.
在本文所揭示之第一、第二及第三實施例之某些實施例中,液體營養組合物含有礦物質,其非限制性實例包括磷、鎂、鐵、鋅、錳、銅、鈉、鉀、鉬、鉻、硒、氯及其組合。 In certain embodiments of the first, second, and third embodiments disclosed herein, the liquid nutritional composition contains minerals, non-limiting examples of which include phosphorus, magnesium, iron, zinc, manganese, copper, sodium, Potassium, molybdenum, chromium, selenium, chlorine and combinations thereof.
儘管以上所呈現之某些實施例包括用於即飲液體營養組合物之營養組合物的調配物,但諸如濃縮液體、液體(例如懸浮液、溶液、乳液、澄清溶液)、可復原粉末、條、半固體、酸酪乳、布丁等之其他產物形式可適用於本文所揭示之各種實施例中的營養組合物。此外,在某些實施例中,組合物可呈凝膠物或凝膠基質之形式。另外,在某些實施例中,所揭示之第一、第二及第三實施例之液體營養組合物可呈冷凍液體營養組合物之形式(亦即,冰棒)或可以適合於消費者將其冷凍之形式封裝(例如諸如冷凍棒)。將第一、第二及第三實施例之液體營養組合物封裝成冰棒或冷凍棒形式之特別優點為:當進行封裝且包括0.75公克至1.5公克β-葡聚糖及6.25公克大豆蛋白時,冷凍營養組合物不形成冰晶體,因此提供更像泥漿之紋理而非結冰或結晶紋理。 While certain embodiments presented above include formulations for nutritional compositions for ready-to-drink liquid nutritional compositions, such as concentrated liquids, liquids (eg, suspensions, solutions, emulsions, clear solutions), reversible powders, strips Other product forms, semi-solid, yogurt, pudding, and the like, are suitable for use in the nutritional compositions of the various embodiments disclosed herein. Moreover, in certain embodiments, the composition can be in the form of a gel or gel matrix. Additionally, in certain embodiments, the liquid nutritional compositions of the first, second, and third embodiments disclosed may be in the form of a frozen liquid nutritional composition (ie, a popsicle) or may be suitable for a consumer to Frozen form packaging (eg such as a freezing bar). A particular advantage of encapsulating the liquid nutritional compositions of the first, second and third embodiments in the form of a popsicle or a frozen stick is that when packaged and comprises from 0.75 grams to 1.5 grams of beta-glucan and 6.25 grams of soy protein, The frozen nutritional composition does not form ice crystals, thus providing a more mud-like texture than ice or crystalline texture.
詳言之,在某些實施例中,營養組合物仍為澄清的但呈半固體之形式,諸如凝膠或其他明膠樣形式;營養組合物包含每千卡營養組合物0.004公克至0.02公克β-葡聚糖,每一份至少一種碳水化合物源6.25公克至20公克蛋白,且每100公克營養組合物不超過1公克之脂肪(亦即,不超過1重量%之脂肪)。在凝膠或明膠樣形式之某些實施例中,至少6.25公克蛋白質為大豆蛋白。一般而言,液體營養組合物之凝膠或明膠樣形式可藉由添加諸如以下之增稠劑形成:明膠、海藻酸鹽、角叉菜膠、果膠、羧甲基纖維素、阿拉伯膠、及β-葡聚糖以及其他增稠劑。 In particular, in certain embodiments, the nutritional composition is still in a clear but semi-solid form, such as a gel or other gelatin-like form; the nutritional composition comprises from 0.004 grams to 0.02 grams per kilocalorie of the nutritional composition. a dextran having from 6.25 grams to 20 grams of protein per at least one carbohydrate source and no more than 1 gram of fat per 100 grams of nutritional composition (i.e., no more than 1% by weight of fat). In certain embodiments of the gel or gelatin-like form, at least 6.25 grams of protein is soy protein. In general, the gel or gelatin-like form of the liquid nutritional composition can be formed by the addition of a thickening agent such as gelatin, alginate, carrageenan, pectin, carboxymethylcellulose, gum arabic, And β-glucan and other thickeners.
本文所揭示之第一、第二及第三實施例之液體營養組合物亦可視情況包括一或多種掩蔽劑以減少或以其他方式掩蓋任何殘餘之苦味的產生及乳液中隨時間產生之後味。合適之掩蔽劑包括天然及人工甜味劑;鈉源,諸如氯化鈉;及水膠體,諸如瓜爾膠、三仙膠、角叉菜膠、結冷膠;及其組合。營養乳液中之掩蔽劑的量可視所選擇之特定掩蔽劑、調配物中之其他成分及其他調配物或產物目標變數而變化。然而,該等量最通常為以營養乳液之重量計至少約0.1%,包括0.1%至3%,包括0.15%至3%,且亦包括約0.18%至2.5%。 The liquid nutritional compositions of the first, second and third embodiments disclosed herein may also optionally include one or more masking agents to reduce or otherwise mask any residual bitterness and subsequent taste in the emulsion. Suitable masking agents include natural and artificial sweeteners; sodium sources such as sodium chloride; and hydrocolloids such as guar gum, tri-gum, carrageenan, gellan gum; and combinations thereof. The amount of masking agent in the nutritional emulsion can vary depending on the particular masking agent selected, the other ingredients in the formulation, and other formulation or product target variables. However, such amounts are most typically at least about 0.1% by weight of the nutritional emulsion, including 0.1% to 3%, including 0.15% to 3%, and also including about 0.18% to 2.5%.
本文所述之液體營養組合物適用於提供營養,且或適用於為個體提供一或多種如本文所述之益處。根據該等方法,液體營養組合物可視需要最通常以每天一至兩份之形式,按每天一或兩個或兩個以上分次劑量經口投與以提供所需營養水準。 The liquid nutritional compositions described herein are suitable for providing nutrition and are or are suitable for providing an individual with one or more of the benefits as described herein. According to such methods, the liquid nutritional composition can be administered orally, usually in the form of one to two servings per day, in one or two or more divided doses per day, to provide the desired level of nutrients.
本文所揭示之第一、第二及第三實施例之液體營養組合物可藉由用於製造營養乳液之任何製程或合適方法(目前已知或將來已知)製造。在一個合適之製造製程中,製備至少兩種各別漿料。此等漿料包括:於水之蛋白質(PIW)漿料及碳水化合物-礦物質(CHO-MIN)漿料。 PIW漿料藉由首先製造Nutriose(抗性澱粉)及Barliv(β-葡聚糖源)之纖維預摻合物而形成。接著將纖維預摻合物緩慢添加至150℉水中。接著將所要數量之Clarisoy(大豆蛋白分離物)添加至纖維水摻合物中。接著使摻合物冷卻至130℉,且接著將所要之任何乳清蛋白添加至蛋白質纖維摻合物中。CHO-MIN漿料藉由向水中添加礦物質(例如檸檬酸鉀、磷酸氫二鉀、檸檬酸鈉等)形成,將痕量及超痕量礦物質(通常作為預混合物)、增厚型或懸浮劑L-肉鹼、蔗糖、麥芽糊精、著色劑、調味劑、甜味劑、葉酸及碘化鉀以及其他物質全部添加至漿料中。 The liquid nutritional compositions of the first, second and third embodiments disclosed herein can be made by any process or suitable method for the manufacture of nutritional emulsions (currently known or known in the future). In a suitable manufacturing process, at least two separate slurries are prepared. Such slurries include: protein in water (PIW) slurries and carbohydrate-mineral (CHO-MIN) slurries. The PIW slurry was formed by first making a fiber pre-blend of Nutriose (resistant starch) and Barliv (beta-glucan source). The fiber preblend was then slowly added to 150 °F water. The desired amount of Clarisoy (soy protein isolate) is then added to the fiber water blend. The blend is then cooled to 130 °F and any desired whey protein is then added to the protein fiber blend. CHO-MIN slurry is formed by adding minerals (such as potassium citrate, dipotassium hydrogen phosphate, sodium citrate, etc.) to water, using traces and ultra-trace minerals (usually as a pre-mix), thickening or Suspensions L-carnitine, sucrose, maltodextrin, coloring agents, flavoring agents, sweeteners, folic acid and potassium iodide, and other materials are all added to the slurry.
將兩種漿料與液體蔗糖、最終之水一起摻合且攪拌,且將pH值調節至所需之範圍(通常低於4.6),此之使組合物經受高溫短時(HTST)處理,其間對組合物熱處理、乳化且均質化,且使其冷卻。 The two slurries are blended with liquid sucrose, the final water and stirred, and the pH is adjusted to the desired range (typically below 4.6), which subjects the composition to high temperature short time (HTST) treatment, during which time The composition is heat treated, emulsified and homogenized and allowed to cool.
以下實例說明本文所揭示之液體營養組合物之特定及例示性實施例及特徵。提供該等實例僅為說明之目的,且不應理解為限制本發明。在不脫離本發明所揭示之液體營養組合物之精神及範疇之情況下,可對此等特定實例進行許多變化。除非另外指示,否則下表中所指示之所有量均為以組合物之總重量計的重量百分比。 The following examples illustrate specific and exemplary embodiments and features of the liquid nutritional compositions disclosed herein. The examples are provided for illustrative purposes only and are not to be construed as limiting the invention. Many variations may be made to these specific examples without departing from the spirit and scope of the liquid nutritional compositions disclosed herein. All amounts indicated in the table below are by weight of the total weight of the composition, unless otherwise indicated.
實例1:根據以下表1中所提供之材料清單製備1000kg水果味澄清之液體營養組合物批料,其每10液盎司份具有蛋白質含量為約9公克之總蛋白質(其中6.25公克為大豆蛋白且其餘為乳清蛋白分離物)、0.75公克β-葡聚糖及100mg L-肉鹼。澄清之液體營養組合物含有0公克脂肪、13公克糖、9公克蛋白,具有每10盎司份152卡路里,且所量測之重量莫耳滲透濃度為253mOSM/kg H2O。當製備該產物時,一般遵循上文所述之製造方法(亦即,製備PIW、CHO-MIN且隨後摻合)。使用檸檬酸將組合物之最終pH值(在滅菌之後)調節至3.2。 Example 1 : A 1000 kg fruit clarified liquid nutritional composition batch was prepared according to the bill of materials provided in Table 1 below, having a total protein of about 9 grams per 10 ounces of the liquid (of which 6.25 grams is soy protein and The remainder was whey protein isolate), 0.75 grams of beta-glucan and 100 mg of L-carnitine. Clarified liquid nutritional composition containing 0 grams of fat, 13 grams of sugar, 9 g protein, with 152 calories per 10 ounces parts, and the measured weight of the molar concentration of the permeate 253mOSM / kg H 2 O. When the product is prepared, the manufacturing process described above is generally followed (i.e., PIW, CHO-MIN is prepared and subsequently blended). The final pH of the composition (after sterilization) was adjusted to 3.2 using citric acid.
實例2:根據以下表2中所提供之材料清單製備1000kg水果味澄清之液體營養組合物批料,其每10液盎司份具有蛋白質含量為約9公克之總蛋白(其中100%為大豆蛋白)、0.75公克β-葡聚糖及100mg L-肉鹼均。當製備該產物時,一般遵循上文所述之製造方法(亦即,製備PIW、CHO-MIN且隨後摻合)。澄清之液體營養組合物含有0公克脂肪、13公克糖、9公克蛋白質,每10液盎司份具有157卡路里,且所量測之重量莫耳滲透濃度為269mOSM/kg H2O。 Example 2 : A 1000 kg fruit clarified liquid nutritional composition batch was prepared according to the bill of materials provided in Table 2 below, having a protein content of about 9 grams total protein (100% of which is soy protein) per 10 fluid ounces. 0.75 g of β-glucan and 100 mg of L-carnitine. When the product is prepared, the manufacturing process described above is generally followed (i.e., PIW, CHO-MIN is prepared and subsequently blended). Clarified liquid nutritional composition containing 0 grams of fat, 13 grams of sugar, 9 grams of protein per 10 fluid ounces with 157 parts of calories, and the measured weight of the molar concentration of the permeate 269mOSM / kg H 2 O.
製備四種所揭示之實施例之液體營養組合物之各別調配物用於嗜好測試。該等調配物包含以下:601:9g具有70/30大豆/乳清摻合物之蛋白質;602:9g具有100%大豆之蛋白質;605:9g添加有50%檸檬酸鉀及50% KCl之具有70/30大豆/乳清的總蛋白;606:9g添加有50%檸檬酸鉀及50% KCl之具有100%大豆的總蛋白。在測試之前,將該等調配物儲存1個月。要求總共41個個體按9分嗜好量表(1=極厭惡,9=極喜歡)來評價四種調配物之總體可接受性。官能檢查員將該等樣品進行分級,且隨後接著收集評論。在室溫下供應樣品。用5盎司編碼有3位數隨機數字的塑膠杯為官能檢查員供應大約3/4盎司之各樣品。用紅燈遮掩該等樣品中之顏色差異。採用方差分析及費雪LSD測試(Fisher LSD test)分析嗜好資料。使用傅里德曼氏等級分析(Friedman's Analysis of Rank)測定等級偏好。在95%信賴水準下測定顯著性。小組之結果展示於以下表3中。 Individual formulations of the liquid nutritional compositions of the four disclosed examples were prepared for preference testing. The formulations comprise the following: 601: 9 g protein with 70/30 soy/whey blend; 602: 9 g protein with 100% soy; 605: 9 g with 50% potassium citrate and 50% KCl 70/30 total protein of soy/whey; 606: 9 g of total protein with 100% soy added with 50% potassium citrate and 50% KCl. The formulations were stored for 1 month prior to testing. A total of 41 individuals were asked to evaluate the overall acceptability of the four formulations on a 9-point preference scale (1 = extreme disgust, 9 = very like). The functional inspector grades the samples and then collects the comments. The sample was supplied at room temperature. Approximately 3/4 ounces of each sample was supplied to the functional inspector using a 5 ounce plastic cup encoded with a 3-digit random number. The difference in color in the samples is masked with a red light. The hobby data were analyzed by analysis of variance and Fisher LSD test. Grade preference was determined using Friedman's Analysis of Rank. Significance was measured at 95% confidence level. The results of the group are shown in Table 3 below.
就術語「包括(includes/including)」用於說明書或申請專利範圍 中而言,其意欲方式與術語「包含(comprising)」類似之包含性,就如同彼術語在申請專利範圍中用作過渡詞時所解釋一般。此外,就採用術語「或」(例如A或B)而言,其意欲意謂「A或B或二者」。當申請者意欲指示「僅A或B而非二者」時,則採用術語「僅A或B而非二者」。因此,本文使用術語「或」為包含性使用,而非排他性使用。參見Bryan A.Garner,A Dictionary of Modern Legal Usage 624(第二版1995)。此外,就術語「在……中(in)」或「至……中(into)」用於說明書或申請專利範圍中而言,其意欲另外意謂「在……上(on)」或「至……上(onto)」。此外,就術語「連接」用於說明書或申請專利範圍中而言,其意欲意謂不僅「直接連接至」,而且「間接連接至」,諸如經由另一個組件或多個組件連接。 As the term "includes/including" is used in the specification or the scope of the patent application, the intended way is similar to the term "comprising", as if the term was used as a transitional word in the scope of the patent application. It is explained in general. In addition, the term "or" (for example, A or B) is used to mean "A or B or both". When the applicant intends to indicate "only A or B and not both", the term "only A or B, not both" is used. Therefore, the term "or" is used herein inclusive, and not exclusively. See Bryan A. Garner, A Dictionary of Modern Legal Usage 624 (Second Edition 1995). In addition, as the term "in" or "into" is used in the specification or patent application, the intention is to mean "on" or "on" To ... on. In addition, the term "connected" is used in the context of the specification or patent application, and it is intended to mean not only "directly connected to" but also "indirectly connected to", such as via another component or components.
雖然本申請案已藉由描述本申請案之實施例來說明,且雖然該等實施例已進行相當詳細描述,但申請者不意欲將隨附申請專利範圍之範疇約束或以任何方式限制於此類詳述。其他優點及修改對熟習此項技術者而言顯而易見。因此,本申請案在其廣泛態樣中不限於所展示及所描述之特定詳述、代表性裝置及說明性實例。因此,可在不脫離申請者之一般發明構思的精神或範疇之情況下偏離該等詳述。 Although the present application has been described by way of the embodiments of the present application, and the embodiments of the present invention are described in detail, the application is not intended to limit or limit the scope of the appended claims Class details. Other advantages and modifications will be apparent to those skilled in the art. Therefore, the application in its broader aspects is not limited to the specific details, Therefore, departures may be made from the details without departing from the spirit and scope of the invention.
Claims (20)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261739273P | 2012-12-19 | 2012-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201438600A true TW201438600A (en) | 2014-10-16 |
Family
ID=49917774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102147329A TW201438600A (en) | 2012-12-19 | 2013-12-19 | Nutritional compositions with heart health benefits |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW201438600A (en) |
| WO (1) | WO2014100358A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040087514A1 (en) * | 2002-09-06 | 2004-05-06 | Hughes Thomas E | Nutritional compositions |
| EP2346361B1 (en) * | 2008-08-29 | 2013-09-18 | Tropicana Products, Inc. | Naturally sweetened juice beverage products with beta-glucan |
| US20120100248A1 (en) * | 2010-08-17 | 2012-04-26 | Abbott Laboratories | Nutritional composition comprising cereal beta-glucan and salacia extract |
| EP2700321A1 (en) * | 2012-08-24 | 2014-02-26 | Etablissements J. Soufflet | Aqueous food composition enriched in beta-glucan |
-
2013
- 2013-12-19 TW TW102147329A patent/TW201438600A/en unknown
- 2013-12-19 WO PCT/US2013/076428 patent/WO2014100358A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014100358A2 (en) | 2014-06-26 |
| WO2014100358A3 (en) | 2014-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102687750B (en) | Weight losing and meal replacement protein type solid beverage | |
| RU2501327C2 (en) | Liquid composition with high protein and fat content | |
| EP2903458B1 (en) | Methods for enhancing the effect of egcg on mitigating skeletal muscle loss | |
| US20160242450A1 (en) | Functional-gel Compositions and Methods | |
| HUP0301793A2 (en) | Carbohydrate system and a method for providing nutriton to a diabetic | |
| BG108570A (en) | Enteral formulations | |
| JP5702042B2 (en) | Concentrated liquid preparation | |
| US20200163370A1 (en) | Liquid nutritional compositions including green tea extract and iron | |
| JP2011505870A (en) | Method for producing functional food product based on egg yolk and product obtained thereby | |
| WO2013148685A1 (en) | Pea protein containing nutritional compositions | |
| TW201717782A (en) | Nutritional compositions and methods for promoting cognitive development | |
| JP2016520664A (en) | Cohesive liquid bolus containing molecules that impart viscoelasticity | |
| US9930906B1 (en) | Protein beverages | |
| TWI592153B (en) | Methods of promoting the healing of diabetic ulcers using beta-hydroxy-beta-methylbutyrate with arginine and glutamine | |
| MX2011010925A (en) | High fiber nutritional emulsions for blood glucose control. | |
| TW201519795A (en) | Anti-regurgitation nutritional composition | |
| CN105007758A (en) | Low buffer nutritional composition and use thereof | |
| RU2591728C2 (en) | Dairy smoothie for stimulating child growth | |
| MX2011010936A (en) | High fiber nutritional emulsions with glycerin. | |
| CA2310659C (en) | Method for accelerating protein digestion rate | |
| RU2391864C2 (en) | Diet correction method for group of patients | |
| US20030091613A1 (en) | Gelled nutritional composition and process | |
| JP5923896B2 (en) | Galate-type catechin-containing food composition | |
| US20150057346A1 (en) | Methods of maintaining intramuscular myoglobin levels, maintaining maximal aerobic capacity, and enhancing the oxidative capacity of muscle in a subject | |
| TW201438600A (en) | Nutritional compositions with heart health benefits |